« Previous article
Save Time, Not Energ...

21st January 2021  Content supplied by: various sources as indicated

Latest Updates on COVID-19 Testing - Kits, Products, Services, Instrumentation - 26 Jan 2021 


Bioperfectus' Rapid Test is Vital for Post-Vaccination Era

Bioperfectus' Rapid Test is Vital for Post-Vaccination Era

Bioperfectus Technologies CE-marked Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit is a rapid chromatographic lateral flow immunoassay that detects the nucleocapsid antigens from nasopharyngeal swabs. Easy-to-use with excellent diagnostic accuracy and just 15 minutes for a result.
Find Out More

 Rapid Test Ag 2019-nCov: Prevent COVID-19 from Spreading!

 Rapid Test Ag 2019-nCov: Prevent COVID-19 from Spreading!

The rapid antigen test of ProGnosis Biotech shows high sensitivity and specificity, has a CE-Mark and is included in the list of approved COVID diagnostic tests by the European Commission, the German BfArM and the Italian Ministry of Health.
Find Out More

Rapid IgM/IgG Antibody Test Vital for COVID-19 Vaccination Program

Rapid IgM/IgG Antibody Test Vital for COVID-19 Vaccination Program

The Novel Corona Virus (SARS-CoV-2) IgM/IgG Rapid Test Kit from Bioperfectus is an in vitro lateral flow diagnostic test used for the detection of novel coronavirus (SARS-CoV-2) IgM and IgG antibodies. It is easy-to-use and provides results in 10-15 minutes. 
Find Out More

AOAC Validates Two More Surface Tests for SARS-CoV-2 

AOAC Validates Two More Surface Tests for SARS-CoV-2 

AOAC has validated Eurofins GeneScan Technologies & ThermoFisher Scientific's SARS-CoV-2 surface kits. The AOAC certification program validates accuracy claims of test kits sold for use in situations when maintaining surfaces free of the virus is a public health concern.
Find Out More

 

New CE-Marked Quantitative SARS-CoV-2 IgG Antibody Test

New CE-Marked Quantitative SARS-CoV-2 IgG Antibody Test

Beckman Coulter has announced CE-marking for its quantitative SARS-CoV-2 IgG Antibody test. The assay is designed to detect antibodies to the spike protein of SARS CoV-2, which is the design of the vaccines on the market today.
Find Out More

 

EU Member States To Create Common List of COVID-19 Rapid Antigen Tests

EU Member States To Create Common List of COVID-19 Rapid Antigen Tests

EU Member states will begin to create a 'common list' of validated rapid antigen tests and share performance data from evaluations. This digital platform will also include RT-PCR test kit data. 
Find Out More

 

Italy, Japan & Brazil Show Confidence in SARS-CoV-2 Microfluidic Rapid Antigen Test

Italy, Japan & Brazil Show Confidence in SARS-CoV-2 Microfluidic Rapid Antigen Test

LumiraDx's microfluidic point-of-care antigen test for SARS-CoV-2 is now available in over 30 countries, including US, Japan & Brazil. The test is designed for nasal or nasopharyngeal swab specimens and a turnaround time-to-result of 12 minutes. 
Find Out More

 

Detect SARS-CoV-2 UK Variant on Same Run As Normal COVID-19 qPCR Test

Detect SARS-CoV-2 UK Variant on Same Run As Normal COVID-19 qPCR Test

Genetic PCR Solutions™ has developed a qPCR reagent kit for the specific genetic detection of the new B.1.1.7 strain described and recently published in the UK. This qPCR can be used on the same patient sample and assayed simultaneously with the usual qPCR test.
Find Out More


    

Tags:

Date Published: 21st January 2021